Display options
Share it on

PLoS One. 2015 Apr 22;10(4):e0124808. doi: 10.1371/journal.pone.0124808. eCollection 2015.

Placebo-induced somatic sensations: a multi-modal study of three different placebo interventions.

PloS one

Florian Beissner, Franziska Brünner, Maria Fink, Karin Meissner, Ted J Kaptchuk, Vitaly Napadow

Affiliations

  1. Somatosensory and Autonomic Therapy Research, Institute of Neuroradiology, Hannover Medical School, 30625, Hannover, Germany; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, 02129, United States of America.
  2. Pain & Autonomics - Integrative Research (PAIR), Department of Psychiatry and Psychotherapy, Jena University Hospital, 07743, Jena, Germany.
  3. Institute of Medical Psychology, Ludwig-Maximilians-University, 80336, Munich, Germany.
  4. Program in Placebo Studies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, United States of America.
  5. Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, 02129, United States of America; Department of Biomedical Engineering, Kyunghee University, Yongin, Korea.

PMID: 25901350 PMCID: PMC4406515 DOI: 10.1371/journal.pone.0124808

Abstract

Somatic sensations induced by placebos are a frequent phenomenon whose etiology and clinical relevance remains unknown. In this study, we have evaluated the quantitative, qualitative, spatial, and temporal characteristics of placebo-induced somatic sensations in response to three different placebo interventions: (1) placebo irritant solution, (2) placebo laser stimulation, and (3) imagined laser stimulation. The quality and intensity of evoked sensations were assessed using the McGill pain questionnaire and visual analogue scales (VAS), while subjects' sensation drawings processed by a geographic information system (GIS) were used to measure their spatial characteristics. We found that all three interventions are capable of producing robust sensations most frequently described as "tingling" and "warm" that can reach consider-able spatial extent (≤ 205 mm²) and intensity (≤ 80/100 VAS). Sensations from placebo stimulation were often referred to areas remote from the stimulation site and exhibit considerable similarity with referred pain. Interestingly, there was considerable similarity of qualitative features as well as spatial patterns across subjects and placebos. However, placebo laser stimulation elicited significantly stronger and more widespread sensations than placebo irritant solution. Finally, novelty seeking, a character trait assessed by the Temperament and Character Inventory and associated with basal dopaminergic activity, was less pronounced in subjects susceptible to report placebo-induced sensations. Our study has shown that placebo-induced sensations are frequent and can reach considerable intensity and extent. As multiple somatosensory subsystems are involved despite the lack of peripheral stimulus, we propose a central etiology for this phenomenon.

References

  1. Pain. 1988 Feb;32(2):251-5 - PubMed
  2. J Bone Joint Surg Am. 1954 Oct;36-A(5):981-97 - PubMed
  3. Conscious Cogn. 2011 Sep;20(3):603-17 - PubMed
  4. J Altern Complement Med. 2007 Dec;13(10):1059-70 - PubMed
  5. Evid Based Complement Alternat Med. 2012;2012:591304 - PubMed
  6. Psychiatr Q. 1968;42(4):653-95 - PubMed
  7. Brain Res. 1997 Jan 2;744(1):121-8 - PubMed
  8. Cereb Cortex. 2015 Sep;25(9):2623-30 - PubMed
  9. N Engl J Med. 2013 Dec 26;369(26):2515-24 - PubMed
  10. Pain. 1984 Nov;20(3):231-45 - PubMed
  11. Neuron. 2007 Jun 7;54(5):677-96 - PubMed
  12. Annu Rev Psychol. 2013;64:49-75 - PubMed
  13. Psychiatr Dev. 1986 Autumn;4(3):167-226 - PubMed
  14. Exp Brain Res. 2009 Sep;198(2-3):261-72 - PubMed
  15. J Neurophysiol. 1993 Jul;70(1):200-12 - PubMed
  16. Forsch Komplementmed. 2010 Oct;17(5):259-64 - PubMed
  17. J Neurosci. 2010 Mar 24;30(12):4353-61 - PubMed
  18. Lancet. 2010 Feb 20;375(9715):686-95 - PubMed
  19. J Neurosci. 2009 Apr 15;29(15):4882-7 - PubMed
  20. Ann Neurol. 2007 Nov;62(5):433-41 - PubMed
  21. BMC Complement Altern Med. 2010;10:81 - PubMed
  22. Evid Based Complement Alternat Med. 2013;2013:620671 - PubMed
  23. Neuroscience. 2012 Aug 16;217:96-104 - PubMed
  24. Nat Rev Drug Discov. 2013 Mar;12(3):191-204 - PubMed
  25. Nat Med. 2010 Nov;16(11):1277-83 - PubMed
  26. Pain. 2002 Apr;96(3):393-402 - PubMed
  27. Evid Based Complement Alternat Med. 2011;2011:485945 - PubMed
  28. Brain. 1978 Jun;101(2):307-32 - PubMed
  29. Pain. 1993 Jul;54(1):99-106 - PubMed
  30. Neuroimage. 2014 Sep;98:216-24 - PubMed
  31. Brain Res. 1999 Sep 25;842(2):452-60 - PubMed
  32. J Clin Epidemiol. 2011 Nov;64(11):1223-9 - PubMed
  33. Neuroimage. 2001 May;13(5):891-5 - PubMed
  34. J Clin Epidemiol. 2000 Aug;53(8):786-92 - PubMed
  35. J Neurol Sci. 1993 Jan;114(1):109-16 - PubMed
  36. J Psychosom Res. 2014 May;76(5):414-21 - PubMed
  37. Neuropsychopharmacology. 2011 Jan;36(1):339-54 - PubMed
  38. BMJ. 2006 Feb 18;332(7538):391-7 - PubMed
  39. Pain. 1975 Sep;1(3):277-99 - PubMed
  40. BMJ. 2014;348:g3253 - PubMed
  41. Curr Rev Pain. 1999;3(6):489-498 - PubMed
  42. Am J Chin Med. 2002;30(1):45-50 - PubMed
  43. Conscious Cogn. 2011 Sep;20(3):784-91 - PubMed
  44. Arch Gen Psychiatry. 1987 Jun;44(6):573-88 - PubMed
  45. BMC Complement Altern Med. 2007;7:33 - PubMed
  46. Lancet. 1994 Oct 22;344(8930):1140-2 - PubMed
  47. Nat Genet. 1996 Jan;12(1):78-80 - PubMed
  48. Neuroimage. 2009 Sep;47(3):1055-65 - PubMed
  49. JAMA Intern Med. 2013 Nov 25;173(21):1941-51 - PubMed
  50. Lancet. 1998 Aug 1;352(9125):364-5 - PubMed
  51. Nat Rev Neurosci. 2010 Jun;11(6):417-28 - PubMed
  52. Pain. 2009 Jul;144(1-2):28-34 - PubMed
  53. J Physiol. 1983 Sep;342:633-54 - PubMed

Substances

MeSH terms

Publication Types

Grant support